24^th World Radiation Oncology Summit

Karol Sikora is Chief Medical Officer of Proton Partners International. He was the founder of Cancer Partners UK which has created UK’s largest independent UK cancer network with private equity. He was Professor and Chairman of the Department of Cancer Medicine at Imperial College School of Medicine and is still honorary Consultant Oncologist at Hammersmith Hospital, London. He is Dean and Professor of Medicine at Britain’s first independent Medical School at the University of Buckingham and a Fellow of Corpus Christi College, Cambridge. He has published over 300 papers and written or edited 20 books including Treatment of Cancer - the standard British postgraduate textbook, now in its sixth edition. His new book for patients The street-wise patient’s guide to cancer survival has just been published.

Integrated Medicine, Medical Oncology, Gene Therapy and Cancer Strategy, Radiation Oncology, Alternative Medicine

Ken H. Young, MD PhD is a Professor in the Department of Hematopathology at the University of Texas MD Anderson Cancer Center. He was Medical Director of Hematology at the University of Wisconsin School of Medicine and University East & West Clinic Laboratories, overseeing the laboratories at the University of Wisconin Hospital and Clinics Core Laboratory. He received his PhD from University of Lund School of Medicine and completed his MD training from Oregon Health Science University. He is board certified in Anatomic and Clinical Pathology and Hematopathology.

His interests are to characterize molecular defects in patients with leukemia and lymphoma by using gene expression profiling, immunophenotypic method, methylation-microRNA-CGH arrays and current NGS molecular technologies with particular interest in tumor suppressor genes, oncogenes, p53 and NF-kB pathways. He has worked extensively on molecular diagnostics for human cancer and has obtained several novel discoveries valuable to predict treatment response, clinical outcome and survival in cancer patients.

Michael Retsky (PhD in Physics from University of Chicago) made a career change to cancer research thirty years ago. He is on staff at Harvard TH Chan School of Public Health and Angiogenesis Foundation, both in Boston. He is also on faculty at University College London. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. Retsky is Editor of a Nature/Springer book on breast cancer to be published in 2017 and Editor-in-Chief of the Journal of Bioequivalence and Bioavailability. He is a founder and on the Board of Directors of the Colon Cancer Alliance and has published more than 60 papers in physics and cancer.

Cancer research, Charged particle optics, Early detection of cancer and delayed detection of cancer.

Prof. Dr. Jan Jacques Michiels Multidisciplinairy Internist Blood Coagulation & Vascular Medicine Center, CEO and Founder of Goodheart Institute in Nature Medicine & Health, Founder and Editor in Chief World Journal of Vascular Medicine: WJVM, Editor in chief Journal of Hematology and Thromboembolic Diseases, Editor of World Journal of Hematology: WJH. Senior Scientific Advisor European Leukemia-Net MPN, Mannheim, European Community, Brussels, Visiting professor Blood & Coagulation Disorders Depts of Hematology of the University Hospital Antwerp, Belgium, University Brno, Czech Republic and Colentina University Hospital, Bucharest, Romania. Prof. Dr. Jan Jacques Michiels is Consultant Professor Bloodcoagulation and Co-Founder of the Hememostasis Research Unit and Von Willebrand Research Laboratory, University Hospital Antwerp, Belgium. Founder International Collaboration and Research in MPN: ICAR; MPN within the European Leukemia-Network: ELN. He is a CoFounder of the Central European Vascular. He is Expert member Leukemia Net, Mannheim, Gernamy (Chair & Founder ELN, Professor Hehlmann, Mannheim). Founder International Collaborations & Academic Research on Von Willebranf Factor and Von Willebrand Disease: ICAR:VWF-VDW. Prof. Dr. Jan Jacques Michiels served as Guest Editor of many of the International Journals in Hematology, Hemostasis, Thrombosis and Vascular Medicine.

Leukemia, Hematology and Thromboembolic Diseases, Haemostasis, Bool & Coagulation Disorders.

Professor Anderson holds the Established Chair in Biomedical Sciences at the University of Bradford. She obtained her first degree in the University of Wales and second degrees in the Faculty of Medicine, University of Manchester. She has an H index of 57, 450+ peer-reviewed papers, 8 books, has successfully supervised 26 PhDs, and been a member of editorial boards of 10 international journals. She has been or is Editor in Chief of a book Series on toxicology for J.Wiley and sons and the Royal Society of Chemistry respectively. She gives key note addresses at various international meetings. She is a consultant for many international organisations, such as the WHO, NATO, TWAS, UNIDO and the OECD.

Cancer, oxygen radicals, human biomonitoring, unbalanced precursor pools, dietary imbalance, male-mediated developmental defects, nanotoxicology, general toxicology.

Dianzheng Zhang has completed his PhD from University of Arizona and Postdoctoral studies from Baylor College of Medicine. He assumed an Assistant Professor position at PCOM in 2006 and promoted to an Associate Professor in 2011. He has published more than 40 papers in reputed journals and has served as a chairman for multiple international conferences.

Hematology

Dr. Bonnie Labdi earned her Doctor of Pharmacy degree from the University of Houston College Of Pharmacy in May of 2002. She completed two years of post-graduate residency through the University of Texas and Scott & White Hospital in June of 2004. She began working at the University of Texas M.D. Anderson Cancer Center in 2004 as a Clinical Pharmacy Specialist, focusing on the areas of hematologic malignancies, specifically lymphoma and myeloma. She remained there for over 6 years before accepting a clinical management position at a two-hospital health system located in Beaumont, Texas. As a clinical manager, she sat on many institutional committees, utilizing her leadership skills and experience in the areas of patient safety, hospital accreditation, and health care management. Most recently, she accepted a clinical specialist position at Memorial Hermann Hospital in Houston, Texas. Her primary areas of focus are in the areas of thoracic and head and neck medical oncology. She sees patients daily in clinic, working in collaboration with oncologists to formulate individualized treatment plans. Besides oncology, Dr. Labdi remains interested and active in the areas of supportive care, patient safety and quality improvement. She serves on several boards and committees of both national and international professional organizations, and is currently serving in her second year as Chairperson of the Publications Committee for the Hematology Oncology Pharmacists Association (HOPA). She has authored a book chapter and several peer-reviewed articles in the fields of oncology and supportive care. She most recently presented 3 talks at the Indo-Global Medical Summit & Expo in Hyderabad, India. She also presented a poster at the most recent World Conference on Lung Cancer annual meeting.

Oncology, Supportive care, Patient safety and Quality Improvement.

Olfat M Hendy completed her MD at the age of 35 years from Clinical pathology department, Menoufia Faclty of Medicine, Menoufia University, Egypt - and become professor of hematology & immunology at the same univerisity at 2009. She is the head of hematology unit at National Liver Institute- Menoufia University, Egypt. She has published more than 28 papers in reputed journals and has been serving as an editorial board member of repute. She was an supervisor on more than 32 MD and master thesis, and discussed more than 32 thesis. She is a membership in about 4 medical societies.

Clinical pathology, Hematology, Hematologic Disorders

Dr. Omar A. Fahmy is a professor of medicine & clinical hematology, Cairo University, where he graduated in 1985. He got his residency at the same institution in the department of medicine, clinical hematology unit, under the supervision of Professor Alaa El-Zayat, the founder of clinical hematology at Cairo University. Prof. Fahmy was honored the title of "The ideal doctor" in 1992 at the annual celebration of the Egyptian medical syndicate. In 1994, he was elected to receive a short post doctoral BMT training course at "Pitie – Salpetriere" hospital, Paris, France, under the supervision of professor JL Binet, the head of the hematology & BMT unit. Shortly afterwards, in 1995, Prof. Fahmy spent 12 months, as a research scholar, at the department of hematology & BMT, Case Western Reserve University, Cleveland, Ohio, USA. During his tenure, he mastered the art of BMT under the supervision of professor Stanton Gerson, the head of the department, & Prof. Hillard Lazarus, the director of the BMT program and the chairman of the ECOG-BMT committee. Currently, Dr. Fahmy is a member of the Lymphoma committee of the MENA region for the NCCN guidelines modifications. In addition, he is a hematology and BMT consultant in several Egyptian centers. He is a member of many professional societies including: the EHOG (Egyptian Hemato-Oncology Group), American Society of Hematology & American Society for Blood and Marrow Transplantation. His main interest is in the field of hematopoietic stem cell transplantation, and published more than 40 articles in that domain in several national and international journals.

Hematology, Hematopoietic Stem Cell Transplantation,

Dr. Nabil Mohie Abdel-Hamid is Professor of Cancer Biology at Department of Biochemistry, Ex- and First Dean and Founder of Faculty of Pharmacy, Kafrelsheikh University, Egypt. Professor Nabil Mohie Abdel-Hamid has many national and international Memberships like Member of The Higher Consulting Organization of Egyptian Scientists Council, Deputy of Director of The Egyptian Association of Cancer Research, member in: The Arab Evaluators for Scientific Degree Promotions and member in The Egyptian Evaluators for Scientific Degree Promotions.

Cancer Biology, Principal Instructor and interested in Hepatocellular Carcinoma Research (Both Early Detection, Looking for New Sensitive and Specific Markers and Therapeutic Perusal), as New Trends in Management of Hepatocellular Carcinoma, Including Chemo and Radio Sensitization to Cancer Therapy.